Cargando…

Correction: Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414394/
https://www.ncbi.nlm.nih.gov/pubmed/32766794
http://dx.doi.org/10.1042/BSR-20190362_COR
_version_ 1783568970076389376
collection PubMed
description
format Online
Article
Text
id pubmed-7414394
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-74143942020-08-13 Correction: Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway Biosci Rep Corrections Portland Press Ltd. 2020-08-07 /pmc/articles/PMC7414394/ /pubmed/32766794 http://dx.doi.org/10.1042/BSR-20190362_COR Text en © 2020 The Author(s). https://creativecommons.org/licenses/by/4.0/ This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
spellingShingle Corrections
Correction: Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway
title Correction: Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway
title_full Correction: Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway
title_fullStr Correction: Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway
title_full_unstemmed Correction: Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway
title_short Correction: Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway
title_sort correction: cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through erk1/2-ap-1 signaling pathway
topic Corrections
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414394/
https://www.ncbi.nlm.nih.gov/pubmed/32766794
http://dx.doi.org/10.1042/BSR-20190362_COR